Decreased postoperative pain and opioid use following prepectoral versus subpectoral breast reconstruction after mastectomy: A retrospective cohort study: Pain after pre- versus subpectoral reconstruction.
Citation: Journal of Plastic, Reconstructive & Aesthetic Surgery: JPRAS. 74(8):1763-1769, 2021 Aug.PMID: 33451949Institution: Washington Cancer InstituteForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Analgesics, Opioid/ad [Administration & Dosage] | *Breast Neoplasms/su [Surgery] | *Mammaplasty/mt [Methods] | *Pain, Postoperative/dt [Drug Therapy] | *Pectoralis Muscles/su [Surgery] | Breast Implants | Female | Humans | Length of Stay/sn [Statistics & Numerical Data] | Mastectomy | Middle Aged | Pain Measurement | Retrospective StudiesYear: 2021Local holdings: Available online from MWHC library: 1995 - presentISSN:- 1748-6815
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 33451949 | Available | 33451949 |
Available online from MWHC library: 1995 - present
BACKGROUND: Prepectoral (PP) breast reconstruction is now commonly performed and minimizes dissection of the pectoralis major muscle. Data are lacking comparing the immediate postoperative recovery of these patients as compared with traditional subpectoral (SP) breast reconstruction.
CONCLUSION: Following mastectomy, PP breast reconstruction results in significantly reduced pain, opioid use, and hospital LOS compared with SP reconstruction. Copyright (c) 2020 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.
METHODS: From December 2015 to February 2017, 73 patients underwent PP prosthetic-based reconstruction at a single academic institution. PP cases were matched 1:1, by age and stage, to patients undergoing traditional SP reconstruction. Analysis of postoperative pain (visual analog scale) and opioid use (oral morphine equivalents, OME), was performed with both bi- and multivariate analyses. Additional outcomes explored included length of stay (LOS) and reconstructive intervention by plane of prosthetic reconstruction.
RESULTS: A total of 146 patients were included in the final cohort. PP reconstruction was associated with higher rates of direct-to-implant reconstruction (84.9% vs. 34.3%, p <0.001) and higher rates of initial prosthetic fill (401.53mL vs. 280.88mL, p<0.001). Patients undergoing PP reconstruction had significantly reduced postoperative pain (4.29vs. 5.44, p<0.001) and in-hospital opioid use (62.63mg OME vs. 98.84mg OME, p=0.03) compared with SP patients. This result remained in multivariate analysis for both pain (3.94vs. 5.25, p<0.001) and opioid use (17.14mg OME vs. 63.03mg OME, p=0.03). Additionally, patients undergoing PP reconstruction had significantly reduced overall LOS on multivariate analysis (21.36vs. 26.28 h, p=0.02).
English